Loading…

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays

The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attr...

Full description

Saved in:
Bibliographic Details
Published in:bioRxiv 2020-11
Main Authors: Mehalko, Jennifer, Drew, Matthew, Snead, Kelly, Denson, John-Paul, Wall, Vanessa, Taylor, Troy, Sadtler, Kaitlyn, Messing, Simon, Gillette, William, Esposito, Dominic
Format: Article
Language:English
Subjects:
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title bioRxiv
container_volume
creator Mehalko, Jennifer
Drew, Matthew
Snead, Kelly
Denson, John-Paul
Wall, Vanessa
Taylor, Troy
Sadtler, Kaitlyn
Messing, Simon
Gillette, William
Esposito, Dominic
description The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production.
doi_str_mv 10.1101/2020.11.18.388868
format article
fullrecord <record><control><sourceid>proquest_COVID</sourceid><recordid>TN_cdi_proquest_journals_2507164130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2507164130</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1828-104445ac0fff23a250dbd77d1563134e2d1df9752c99bf25ce1b1949dba7a8a63</originalsourceid><addsrcrecordid>eNo1kM9LwzAcxYMgbsz9AV4k4EUPmfkmbZMc5_w1GAibCp5K2iSjc21q0gr77604T-8dHp_HewhdAJ0BULhllP26GcgZl1Jm8gSNWaYYkYymIzSNcUcpZSoDLpIzNOKc8YyCGKOPZd0G_20NHsT0ZVf5BnuHN_P1hiz8O2E4ttWnxcGWtu18IEXVmKrZYuNrXTX4en13f4OdDzja4Pd-e8A6Rn2I5-jU6X2006NO0Nvjw-vimaxenpaL-Yq0IJkkQJMkSXVJnXOMa5ZSUxghDKQZB55YZsA4JVJWKlU4lpYWClCJMoUWWuqMT9DVH3cY8NXb2OU734dmqMwHmIAsAU6H1OUx1Re1NXkbqlqHQ_7_BP8B9VVdQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2507164130</pqid></control><display><type>article</type><title>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</title><source>Coronavirus Research Database</source><creator>Mehalko, Jennifer ; Drew, Matthew ; Snead, Kelly ; Denson, John-Paul ; Wall, Vanessa ; Taylor, Troy ; Sadtler, Kaitlyn ; Messing, Simon ; Gillette, William ; Esposito, Dominic</creator><creatorcontrib>Mehalko, Jennifer ; Drew, Matthew ; Snead, Kelly ; Denson, John-Paul ; Wall, Vanessa ; Taylor, Troy ; Sadtler, Kaitlyn ; Messing, Simon ; Gillette, William ; Esposito, Dominic</creatorcontrib><description>The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production.</description><identifier>EISSN: 2692-8205</identifier><identifier>DOI: 10.1101/2020.11.18.388868</identifier><identifier>PMID: 33236017</identifier><language>eng</language><publisher>United States: Cold Spring Harbor Laboratory Press</publisher><subject>Affinity chromatography ; Antigens ; Cell culture ; Chromatography ; Deoxyribonucleic acid ; DNA ; Enzyme-linked immunosorbent assay ; Gel electrophoresis ; Investigations ; Metal ions ; Molecular weight ; Polyacrylamide ; Protein purification ; Proteins ; Serology ; Severe acute respiratory syndrome coronavirus 2 ; Signal peptides ; Sodium lauryl sulfate ; Spike protein ; Streptavidin</subject><ispartof>bioRxiv, 2020-11</ispartof><rights>2020. This article is published under https://creativecommons.org/publicdomain/zero/1.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2507164130?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>780,784,27925,38516,43895</link.rule.ids><linktorsrc>$$Uhttps://www.proquest.com/docview/2507164130?pq-origsite=primo$$EView_record_in_ProQuest$$FView_record_in_$$GProQuest$$Hfree_for_read</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33236017$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehalko, Jennifer</creatorcontrib><creatorcontrib>Drew, Matthew</creatorcontrib><creatorcontrib>Snead, Kelly</creatorcontrib><creatorcontrib>Denson, John-Paul</creatorcontrib><creatorcontrib>Wall, Vanessa</creatorcontrib><creatorcontrib>Taylor, Troy</creatorcontrib><creatorcontrib>Sadtler, Kaitlyn</creatorcontrib><creatorcontrib>Messing, Simon</creatorcontrib><creatorcontrib>Gillette, William</creatorcontrib><creatorcontrib>Esposito, Dominic</creatorcontrib><title>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</title><title>bioRxiv</title><addtitle>bioRxiv</addtitle><description>The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production.</description><subject>Affinity chromatography</subject><subject>Antigens</subject><subject>Cell culture</subject><subject>Chromatography</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Gel electrophoresis</subject><subject>Investigations</subject><subject>Metal ions</subject><subject>Molecular weight</subject><subject>Polyacrylamide</subject><subject>Protein purification</subject><subject>Proteins</subject><subject>Serology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signal peptides</subject><subject>Sodium lauryl sulfate</subject><subject>Spike protein</subject><subject>Streptavidin</subject><issn>2692-8205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNo1kM9LwzAcxYMgbsz9AV4k4EUPmfkmbZMc5_w1GAibCp5K2iSjc21q0gr77604T-8dHp_HewhdAJ0BULhllP26GcgZl1Jm8gSNWaYYkYymIzSNcUcpZSoDLpIzNOKc8YyCGKOPZd0G_20NHsT0ZVf5BnuHN_P1hiz8O2E4ttWnxcGWtu18IEXVmKrZYuNrXTX4en13f4OdDzja4Pd-e8A6Rn2I5-jU6X2006NO0Nvjw-vimaxenpaL-Yq0IJkkQJMkSXVJnXOMa5ZSUxghDKQZB55YZsA4JVJWKlU4lpYWClCJMoUWWuqMT9DVH3cY8NXb2OU734dmqMwHmIAsAU6H1OUx1Re1NXkbqlqHQ_7_BP8B9VVdQA</recordid><startdate>20201118</startdate><enddate>20201118</enddate><creator>Mehalko, Jennifer</creator><creator>Drew, Matthew</creator><creator>Snead, Kelly</creator><creator>Denson, John-Paul</creator><creator>Wall, Vanessa</creator><creator>Taylor, Troy</creator><creator>Sadtler, Kaitlyn</creator><creator>Messing, Simon</creator><creator>Gillette, William</creator><creator>Esposito, Dominic</creator><general>Cold Spring Harbor Laboratory Press</general><scope>NPM</scope><scope>8FE</scope><scope>8FH</scope><scope>AAFGM</scope><scope>AAMXL</scope><scope>ABOIG</scope><scope>ABUWG</scope><scope>ADZZV</scope><scope>AFKRA</scope><scope>AFLLJ</scope><scope>AFOLM</scope><scope>AGAJT</scope><scope>AQTIP</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQCXX</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20201118</creationdate><title>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</title><author>Mehalko, Jennifer ; Drew, Matthew ; Snead, Kelly ; Denson, John-Paul ; Wall, Vanessa ; Taylor, Troy ; Sadtler, Kaitlyn ; Messing, Simon ; Gillette, William ; Esposito, Dominic</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1828-104445ac0fff23a250dbd77d1563134e2d1df9752c99bf25ce1b1949dba7a8a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Affinity chromatography</topic><topic>Antigens</topic><topic>Cell culture</topic><topic>Chromatography</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Gel electrophoresis</topic><topic>Investigations</topic><topic>Metal ions</topic><topic>Molecular weight</topic><topic>Polyacrylamide</topic><topic>Protein purification</topic><topic>Proteins</topic><topic>Serology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signal peptides</topic><topic>Sodium lauryl sulfate</topic><topic>Spike protein</topic><topic>Streptavidin</topic><toplevel>online_resources</toplevel><creatorcontrib>Mehalko, Jennifer</creatorcontrib><creatorcontrib>Drew, Matthew</creatorcontrib><creatorcontrib>Snead, Kelly</creatorcontrib><creatorcontrib>Denson, John-Paul</creatorcontrib><creatorcontrib>Wall, Vanessa</creatorcontrib><creatorcontrib>Taylor, Troy</creatorcontrib><creatorcontrib>Sadtler, Kaitlyn</creatorcontrib><creatorcontrib>Messing, Simon</creatorcontrib><creatorcontrib>Gillette, William</creatorcontrib><creatorcontrib>Esposito, Dominic</creatorcontrib><collection>PubMed</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>bioRxiv</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mehalko, Jennifer</au><au>Drew, Matthew</au><au>Snead, Kelly</au><au>Denson, John-Paul</au><au>Wall, Vanessa</au><au>Taylor, Troy</au><au>Sadtler, Kaitlyn</au><au>Messing, Simon</au><au>Gillette, William</au><au>Esposito, Dominic</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</atitle><jtitle>bioRxiv</jtitle><addtitle>bioRxiv</addtitle><date>2020-11-18</date><risdate>2020</risdate><eissn>2692-8205</eissn><abstract>The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production.</abstract><cop>United States</cop><pub>Cold Spring Harbor Laboratory Press</pub><pmid>33236017</pmid><doi>10.1101/2020.11.18.388868</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier EISSN: 2692-8205
ispartof bioRxiv, 2020-11
issn 2692-8205
language eng
recordid cdi_proquest_journals_2507164130
source Coronavirus Research Database
subjects Affinity chromatography
Antigens
Cell culture
Chromatography
Deoxyribonucleic acid
DNA
Enzyme-linked immunosorbent assay
Gel electrophoresis
Investigations
Metal ions
Molecular weight
Polyacrylamide
Protein purification
Proteins
Serology
Severe acute respiratory syndrome coronavirus 2
Signal peptides
Sodium lauryl sulfate
Spike protein
Streptavidin
title Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A17%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_COVID&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20production%20of%20SARS-CoV-2%20spike%20receptor-binding%20domain%20(RBD)%20for%20serology%20assays&rft.jtitle=bioRxiv&rft.au=Mehalko,%20Jennifer&rft.date=2020-11-18&rft.eissn=2692-8205&rft_id=info:doi/10.1101/2020.11.18.388868&rft_dat=%3Cproquest_COVID%3E2507164130%3C/proquest_COVID%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p1828-104445ac0fff23a250dbd77d1563134e2d1df9752c99bf25ce1b1949dba7a8a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2507164130&rft_id=info:pmid/33236017&rfr_iscdi=true